RAS inhibitor daraxonrasib shows promising early anti-tumor effects in pancreatic cancer
In a groundbreaking advancement in the fight against pancreatic cancer, researchers at The University of Texas MD Anderson Cancer Center ...
In a groundbreaking advancement in the fight against pancreatic cancer, researchers at The University of Texas MD Anderson Cancer Center ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine